Repeat scans for monitoring pulmonary embolism
Part of Heart & circulation, Lungs & breathing clinical trials.
This trial is testing if repeated imaging can help monitor blood clots in the lungs (pulmonary embolism) over time. It may help doctors know how well treatment is working and if further care is needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a pulmonary embolism (PE) at Sahlgrenska University Hospital
- You can understand and sign a consent form
- You are not at very high risk (based on certain tests) if you join the first group (Cohort A)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is a registry that collects information about people with a recent lung blood clot diagnosed by CT scan. It particularly focuses on higher-risk cases to better understand outcomes and care in the first 2 weeks after symptoms start.
This study tests a new, non-invasive imaging method called pulsatile electrical impedance tomography (EIT) to help diagnose and monitor acute pulmonary embolism (blood clots in the lungs). It may provide a faster or safer way to detect clots compared to standard CT scans, especially for patients who cannot have contrast dye.
This trial tests a procedure that uses ultrasound to guide a catheter that delivers clot-dissolving medicine directly to a blood clot in the lungs. It is for people who have a pulmonary embolism that causes some heart strain but who are not in shock.
This trial tests a new device that removes blood clots from the lungs through a small tube. It is for people with a recent pulmonary embolism who have slightly strained hearts but stable blood pressure.
This study records information about people who have had a pulmonary embolism, so researchers can learn how patients do over time. It may help improve understanding of outcomes and care patterns for future patients.
This study uses heart signals and blood tests to predict how well your heart will recover over a year after a pulmonary embolism. It may help doctors tailor your care based on your personal risk.
Hear when a new Pulmonary Embolism (Diagnosis) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.